Effect of Hormone Replacement Therapy on Liver and Cardiometabolic Outcomes in Peri‐Menopausal <scp>MASLD</scp>
Treatment of peri-menopausal symptoms with HRT, in patients with pre-existing MASLD, is associated with a lower 5-year risk of major liver and cardiometabolic disease. These findings support early basic science research and should prompt a closer examination through clinical trials.
Authors
- David R. J. Riley (ORCID: https://orcid.org/0000-0002-0905-6524)
- Alex E. Henney (ORCID: https://orcid.org/0000-0002-8066-9470)
- Uazman Alam
- Jo Wilson
Institutions
- University of Liverpool (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Liverpool Womens NHS Foundation Trust (GB)
Publication Details
- Journal
- Liver International
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1111/liv.70562
- Citations
- 1
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 30.73